Search the Newsreel

PDS Biotechnology (PDSB) cuts R&D spend but warns on going concern, cash at $5.6M

PDS Biotechnology reported a net loss of $17.1 million for the six months ended June 30, 2026, with cash and cash equivalents significantly reduced to $5.6 million from $26.7 million at year-end 2025. The company's management disclosed substantial doubt about its ability to continue …

PDSB Maintained by HC Wainwright & Co. -- Price Target Lowered t

PDS Biotechnology reports Q2 2026 net loss $9.8M, cash $5.6M, strategic refocus on PDS0301

PDS Biotechnology reported a net loss of $9.8 million for Q2 2026 and had $5.6 million in cash at quarter-end. The company announced a strategic refocus to prioritize its tumor-targeted IL-12 program, PDS0301, and will discontinue internal investment in PDS0101, seeking external partnerships for …

PDS Biotechnology: Q2 Earnings Snapshot

PDS Biotech Reports Second Quarter 2026 Financial Results

PDS Biotechnology Corporation announced its financial results for the second quarter ended June 30, 2026, reporting a net loss of $9.8 million. The company also provided a clinical and corporate update, highlighting positive clinical data for PDS0301 in metastatic colorectal cancer and announcing a …

PDS Biotechnology Halts PDS0101 Trial, Pivots to PDS0301 in Colorectal Cancer

PDS Biotechnology has announced the halt of its PDS0101 trial and internal investment, including the discontinuation of the Phase 3 VERSATILE-003 trial, to pivot its resources towards PDS0301. PDS0301, a tumor-targeted IL-12 immunocytokine, will now be the company's lead asset with a priority indication …

Is Precision Drilling (TSX:PD) A Bargain Following Higher Sales And A Quarterly Loss?

PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program

PDS Biotechnology Corporation's stock crashed by approximately 67% after the company announced a strategic refocus of its resources towards the PDS0301 program for metastatic colorectal cancer. This shift is based on encouraging clinical data and a belief that PDS0301 offers a more attractive path …

PDS Biotech to report quarterly financial results

PDS Biotech has scheduled the release of its quarterly financial results for the quarter ending June 30, 2026, on August 13, 2026. This announcement was initially published by PDS Biotechnology Corporation via GlobeNewswire. The news brief was created by Public Technologies (PUBT) using generative …

Form 8K PDS Biotechnology Corp For: 11 August By Investing.com

This article announces the filing of a Form 8K by PDS Biotechnology Corp for August 11, as reported by Investing.com. It provides a brief update on company filings without further details on the content of the Form 8K. The article appears to be a …

PDS0301 Data Show 80% 24-Month Survival With Liver Metastases

PDS Biotechnology (Nasdaq: PDSB) announced a strategic refocus, prioritizing its tumor-targeted IL-12 immunocytokine PDS0301 and discontinuing internal investment in the PDS0101 Phase 3 VERSATILE-003 trial, instead seeking strategic partnerships for PDS0101. This decision follows promising Phase 2 data for PDS0301 in metastatic colorectal cancer …

Precision Drilling Corporation (PDS) Stock Forecasts

This article provides stock forecasts for Precision Drilling Corporation (PDS), detailing an analyst's report from Argus. The report lowers PDS's target price to $72.00, despite the company's current price being $83.02. Precision Drilling Corp is identified as a provider of contract drilling and completion …

PDS Biotechnology Corp (PDSB) Earnings Forecast: Future EPS & Revenue Growth Estimates

Wall Street Zen Downgrades Precision Drilling (NYSE:PDS) to Hold

Wall Street Zen has downgraded Precision Drilling (NYSE:PDS) from a "buy" to a "hold" rating, despite a "Moderate Buy" consensus from other analysts with an average price target of $122.33. The company's shares opened at $75.65, a 1.7% decline, and it currently holds a …

Precision Drilling Corporation (NYSE:PDS) Receives Average Recommendation of "Moderate Buy" from Analysts

Precision Drilling Corporation (NYSE:PDS) has received an average "Moderate Buy" recommendation from eight analysts, with an average 12-month price target of $122.33. The stock opened at $77.59, and institutional investors own 48.86% of the company, with several firms increasing their stakes. Analyst ratings have …

Precision Drilling Corp (PDS) Stock News Today

This page provides news and analysis for Precision Drilling Corp (PDS) stock. As of August 7th, the stock was trading at $75.750, down 1.65%. The latest news highlights a broader market trend of AI spending shock triggering a tech rout and crypto selloff.

Precision Drilling Corp (PDS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Precision Drilling Corp (PDS), including future EPS and revenue growth estimates. Based on 6 analysts, the stock has a "Buy" trend with an average price target of USD 110.26. The expected revenue for the next quarter is …

PDS Limited Q1FY27 net profit rises 43% to ₹286 crore on revenue surge

PDS Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

PDS Biotechnology Corp (PDSB) Stock News Today

FIL Limited (PDS) discloses 5.6% Precision Drilling holding via affiliated entities

FIL Limited and its affiliated entities have reported a 5.6% beneficial ownership stake in Precision Drilling Corp (PDS) as of June 30, 2026, through a passive Schedule 13G/A filing. This ownership amounts to 719,507 shares of common stock, with FIL Limited holding sole voting …

Analysts Offer Insights on Energy Companies: Precision Drilling (PDS) and Freehold Royalties (OtherFRHLF)

Analysts have provided new ratings for Precision Drilling (PDS) and Freehold Royalties (FRHLF) in the Energy sector. TD Cowen analyst Aaron Macneil maintained a Hold rating on Precision Drilling with a C$116.00 price target, while TipRanks – PerPlexity downgraded it to Hold. For Freehold …

Dimensional Fund Advisors LP Raises Stake in Precision Drilling Corporation $PDS

Dimensional Fund Advisors LP significantly increased its stake in Precision Drilling Corporation (NYSE:PDS) by 37.0% in the first quarter, now owning 288,013 shares worth $28.34 million. Institutional investors collectively hold 48.86% of the company's stock. Analyst sentiment is a "Moderate Buy" with an average …

PDS Limited Schedules Q1 FY27 Earnings Call With Senior Management

Precision Drilling Corp. Eyes Margin Rebound Amid Risks

Precision Drilling Corp.'s Q2 earnings call revealed solid revenue growth and record Canadian rig activity, but also softer EBITDA and a net loss, particularly due to U.S. and international market pressures. The company plans for margin recovery, disciplined capital spending, and debt reduction, despite …

Precision Drilling (TSX:PD) Stock Trails Revenue Growth As Margins Crack

Precision Drilling (TSX:PD) Navigates Margin Pressure Amid Growth

Precision Drilling Corp (PDS) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Precision Drilling Corp (PDS), noting its current valuation score of 9.35, placing it 11th out of 88 in its industry. It highlights the company's P/E ratio of -101.89, which is significantly below its recent high and above its …

Earnings call transcript: Precision Drilling Q2 2026 profit miss hits shares

Precision Drilling (PD) reported higher Q2 2026 revenue but a significant earnings miss due to U.S. rig reactivation costs and restructuring charges, despite stronger Canadian drilling activity. The company's shares fell over 7% following the announcement, though management expects improved U.S. margins in H2 …

Precision Drilling (NYSE:PDS) Stock Price Down 7.4% - Should You Sell?

Precision Drilling (NYSE:PDS) shares dropped 7.4% on Wednesday, with trading volume significantly below average, and the stock now trades below its 50-day and 200-day moving averages. Analyst sentiment is mixed, with some downgrading the stock to sell-equivalent ratings while others maintain Buy or Outperform …

Earnings Flash (PD.TO) Precision Drilling Reports Q2 Revenue C$452.8M, Vs. FactSet Est of C$441.3M

Precision Drilling Corporation (PD.TO) announced its Q2 earnings, reporting revenue of C$452.8 million. This figure exceeded FactSet's estimated revenue of C$441.3 million.

Precision Drilling (NYSE: PDS) Q2 2026 revenue grows as earnings turn negative

Precision Drilling Corporation reported an 11.4% year-over-year revenue increase to $452.8 million in Q2 2026, driven by strong Canadian and U.S. drilling activity. Despite revenue growth, the company swung to a net loss of $893 thousand due to higher operating costs, increased depreciation, and …

Precision Drilling (NYSE: PDS) Q2 2026 growth, margins and CRA tax dispute

Precision Drilling reported an 11% increase in Q2 2026 revenue, reaching $452.8 million, driven by strong Canadian and U.S. drilling activity. However, Adjusted EBITDA declined by 10% to $97.1 million due to higher U.S. rig reactivation costs, international margin pressure, and restructuring charges, resulting …